June Emerging Medical Technologies Report

Table of Contents

BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED

• A barrier film medical device platform which separates adjacent organs from adhering to each other after surgery
• A device for hydrophilic guidewire control, as an alternative to a torque device
• A diagnostic biomarker that can be applied to a breast cancer patient's tumor sample to predict whether she would benefit from taxane-based chemotherapy
• A fast, secure closure system for intravenous access catheters that eliminates blood loss, cross contamination and reduces nursing labor
• A technology for harvesting autogolous, adipose-derived stem cells for use in treating knee, back and joint pain, arthritis or ligament or tendon injuries
• Affordable portable, power-free, surgical instrument sterilization
• An orthopedic table extension to assist surgeons in performing minimally invasive direct anterior hip replacement surgery
• Biocompatible, rice-grain sized, subdermal implant with a proprietary nanoporous membrane to provide long-term, constant-rate delivery of therapeutic macromolecules for up to a year
• Biomedical devices for delivering anesthesia
• Carbon nanotube fiber technology to treat ventricular arrhythmia
• Catheter device that enables chemotherapy delivery in a targeted manner, reducing patient side effects and improving treatment efficacy
• Collagen replenishment therapies for soft tissue therapeutic applications
• Cost-effective vein visualization tool that increases the ability of nurses, physicians, and caregivers to locate and easily access veins for IVs, shots and blood samples
• Disposable electroencephalography (EEG) and cerebral function monitoring (CFM) products for term and preterm infants
• Effective and cost competitive proprietary scaffold technology for the healing of chronic wounds, that incorporates oxygen and pro-regeneration molecule delivery
• Electrical-based treatment to remineralize tooth defects/decay
• Embolic microspheres and delivery system for the peripheral vascular treatment of disorders such as uterine fibroids, hepatocellular carcinoma and benign prostatic hyperplasia
• Hand-held, integrated, real-time, nanoparticle-based diagnostic device to detect staph and other bacterial infections at the point of care in 30 minutes or less
• Innovative blood pumps based on membrane wave technology
• Low cost, simple-to-use, handheld laboratory for 15-minute diagnosis of disease at the patient's side
• Magnetic intra-ureteral stent that employs a proximity sensing system to allow surgeons to more precisely localize and avoid the ureter during pelvic and colorectal surgeries
• Microfluidic bioreactor technology to produce the world's first donor-independent human platelets from human induced pluripotent stem cells
• Neuro diagnostic information device with a particular focus on concussion (mTBI) and Alzheimer's disease
• Pharmacological materials including mesenchymal stem cells into a bioengineered polymer gel topically applied to non-healing wounds in all clinical care settings
• Proprietary products for single-cell analysis and characterization using picodroplets
• The first antibacterial catheter to be self-sterilizing while residing in a patient
• Tissue-engineered nerve grafts for repairing damage to the peripheral and central nervous systems, involving peripheral nerve injury, spinal cord injury, traumatic brain injury and stroke
• Transcatheter mitral valve replacement system to treat patients with mitral regurgitation
• Transdermal drug delivery technology
• Wearable technology solution that continuously and non-invasively monitors blood glucose levels, and communicates the data to a mobile phone